Brand Ozempic vs Compounded Semaglutide: Cost, Quality, and Differences

Why Compounded Semaglutide Exists

Semaglutide became available in two brand-name formulations: Ozempic® (for type 2 diabetes) and Wegovy® (for weight management). Both are manufactured by Novo Nordisk and have faced severe supply shortages since 2022 as demand skyrocketed.

When a drug appears on the FDA's drug shortage list, federal law permits state-licensed compounding pharmacies to prepare customized versions of that drug. This is why compounded semaglutide became legal and widely available — and why it has become the primary access point for many patients.

What Is Pharmaceutical Compounding?

Pharmaceutical compounding is the process of creating a customized medication from active pharmaceutical ingredients (API). Compounded semaglutide contains the same active ingredient (semaglutide) as brand-name products but is produced by a compounding pharmacy rather than Novo Nordisk.

Cost: The Stark Reality

Wegovy® costs $1,300-$1,600/month without insurance. Ozempic® costs $900-$1,200/month. Compounded semaglutide through a telehealth provider like AvataCore costs $150-$350/month — a savings of over $1,000 per month for most patients. See AvataCore pricing →

Quality and Safety: What to Know

How Compounding Pharmacies Are Regulated

Not all compounding pharmacies are equal. Reputable telehealth providers partner with state-licensed compounding pharmacies that operate under strict sterile-compounding quality standards, prepare medications only in response to valid prescriptions from licensed providers, and source active pharmaceutical ingredients from reputable suppliers. Quality assurance at these pharmacies typically includes independent potency and sterility testing, certificates of analysis (COAs) available on request, and oversight by their respective state boards of pharmacy.

What to Ask Before Ordering

• Is the pharmacy licensed by the state board of pharmacy in its home state?
• Is the active pharmaceutical ingredient sourced from a reputable supplier?
• Are certificates of analysis (COAs) available for each batch?
• Is the medication produced under sterile conditions?

Are There Any Differences in the Drug Itself?

The active ingredient — semaglutide — is the same. However, compounded versions may differ in formulation (some add vitamin B12), concentration, and excipients (inactive ingredients).

Regulatory Landscape

In early 2025, the FDA removed semaglutide from its shortage list, triggering a period of regulatory change. Compounded semaglutide remains available through many licensed providers as of 2026. Working with an established telehealth provider ensures you always have the most current guidance.